SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.50+0.5%3:09 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (17878)3/26/1998 12:42:00 PM
From: tuck  Read Replies (1) of 32384
 
Henry,

You wrote: " A new alliance or two would also come as no surprise. In fact I would be surprised if one or two were not announced fairly soon."

Would you care to expand on this a tad? What in the pipeline is left to negotiate with that doesn't have to do with Ligand's core businesses (cancer, female health, and (drat, I think it's) metabolic disease)?

By the way, you remember our little debate about rexinoids and triglycerides? I'm told the serum levels jump briefly but sharply after each dose. Transient, yes, but a daily problem. I am told it's the chief downside to the compounds (others didn't exist or were to minor to merit comment, apparently).

Regards, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext